Adoptive transfer of lymphocytes transduced with MAGE-A4-specific TCR gene following lymphodepleting conditioning for therapy-resistant esophageal cancer
Latest Information Update: 12 May 2016
At a glance
- Drugs TBI 1201 (Primary) ; Cyclophosphamide
- Indications Oesophageal cancer
- Focus Adverse reactions
- 21 Sep 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
- 20 May 2013 New trial record